A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
Clinical trial NCT07016269 · RECRUITING
Trial details
- NCT number
- NCT07016269
- Sponsor
- Myungmoon Pharma. Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2027-11-10
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.